NO20081010L - Farmasoytisk forbindelse inneholdende kornet pantoprazol - Google Patents
Farmasoytisk forbindelse inneholdende kornet pantoprazolInfo
- Publication number
- NO20081010L NO20081010L NO20081010A NO20081010A NO20081010L NO 20081010 L NO20081010 L NO 20081010L NO 20081010 A NO20081010 A NO 20081010A NO 20081010 A NO20081010 A NO 20081010A NO 20081010 L NO20081010 L NO 20081010L
- Authority
- NO
- Norway
- Prior art keywords
- pantoprazole
- compound containing
- pharmaceutical compound
- containing granular
- particle size
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05016555A EP1747776A1 (fr) | 2005-07-29 | 2005-07-29 | Composition pharmaceutique comprenant du pantoprazole granulaire |
PCT/EP2006/064824 WO2007014928A1 (fr) | 2005-07-29 | 2006-07-29 | Préparation pharmaceutique comprenant du pantoprazole granulaire |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20081010L true NO20081010L (no) | 2008-04-16 |
Family
ID=35149583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20081010A NO20081010L (no) | 2005-07-29 | 2008-02-26 | Farmasoytisk forbindelse inneholdende kornet pantoprazol |
Country Status (9)
Country | Link |
---|---|
EP (2) | EP1747776A1 (fr) |
EA (1) | EA014187B1 (fr) |
HR (1) | HRP20170591T1 (fr) |
NO (1) | NO20081010L (fr) |
PL (1) | PL1909761T3 (fr) |
PT (1) | PT1909761T (fr) |
SI (1) | SI1909761T1 (fr) |
UA (1) | UA86541C2 (fr) |
WO (1) | WO2007014928A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITFI20070253A1 (it) * | 2007-11-09 | 2009-05-10 | Valpharma Internat S P A | Formulazioni farmaceutiche per la somministrazione di ipp. |
EP2133072A1 (fr) | 2008-06-13 | 2009-12-16 | KRKA, D.D., Novo Mesto | Compositions orales pharmaceutiques gastro-résistantes comportant du duloxétine ou ses dérivés pharmaceutiques acceptables |
AU2013204533B2 (en) * | 2012-04-17 | 2017-02-02 | Astrazeneca Ab | Crystalline forms |
KR102419769B1 (ko) | 2016-08-11 | 2022-07-13 | 아다미스 파마슈티칼스 코포레이션 | 약물 조성물 |
US11564910B2 (en) | 2017-12-08 | 2023-01-31 | Adamis Pharmaceuticals Corporation | Drug compositions |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL75400A (en) | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
GB2189699A (en) | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated acid-labile medicaments |
YU48263B (sh) * | 1991-06-17 | 1997-09-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh. | Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola |
DK1037607T3 (da) * | 1997-12-08 | 2004-06-21 | Altana Pharma Ag | Hidtil ukendt suppositoriumsform, der omfatter en syrelabil aktiv forbindelse |
WO2000040224A1 (fr) * | 1999-01-07 | 2000-07-13 | Elan Corporation, Plc | Formes posologiques orale multiparticulaires |
CA2430824C (fr) * | 2000-12-07 | 2012-05-08 | Altana Pharma Ag | Preparation pharmaceutique sous forme de suspension contenant un ingredient actif labile en milieu acide |
TW200410955A (en) * | 2002-07-29 | 2004-07-01 | Altana Pharma Ag | Novel salt of (S)-PANTOPRAZOLE |
CL2004000983A1 (es) * | 2003-05-08 | 2005-03-04 | Altana Pharma Ag | Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y |
US20050031700A1 (en) * | 2003-07-18 | 2005-02-10 | Sanatarus, Inc. | Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders |
TWI372066B (en) * | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
HU227317B1 (en) | 2003-11-25 | 2011-03-28 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | Enteric coated tablet containing pantoprazole |
-
2005
- 2005-07-29 EP EP05016555A patent/EP1747776A1/fr not_active Withdrawn
-
2006
- 2006-07-29 UA UAA200802687A patent/UA86541C2/ru unknown
- 2006-07-29 SI SI200632163A patent/SI1909761T1/sl unknown
- 2006-07-29 EA EA200800443A patent/EA014187B1/ru not_active IP Right Cessation
- 2006-07-29 EP EP06764269.4A patent/EP1909761B1/fr active Active
- 2006-07-29 WO PCT/EP2006/064824 patent/WO2007014928A1/fr active Application Filing
- 2006-07-29 PT PT67642694T patent/PT1909761T/pt unknown
- 2006-07-29 PL PL06764269T patent/PL1909761T3/pl unknown
-
2008
- 2008-02-26 NO NO20081010A patent/NO20081010L/no not_active Application Discontinuation
-
2017
- 2017-04-12 HR HRP20170591TT patent/HRP20170591T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
PT1909761T (pt) | 2017-04-13 |
EP1909761A1 (fr) | 2008-04-16 |
EP1909761B1 (fr) | 2017-01-18 |
EP1747776A1 (fr) | 2007-01-31 |
WO2007014928A1 (fr) | 2007-02-08 |
SI1909761T1 (sl) | 2017-07-31 |
UA86541C2 (ru) | 2009-04-27 |
EA200800443A1 (ru) | 2008-06-30 |
PL1909761T3 (pl) | 2017-08-31 |
EA014187B1 (ru) | 2010-10-29 |
HRP20170591T1 (hr) | 2017-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20081010L (no) | Farmasoytisk forbindelse inneholdende kornet pantoprazol | |
DK1852428T3 (da) | 4-Cyclopropyl-1,2,3-thiadiazolforbindelse, landbrugs- og gartneriplantesygdomskontrolmiddelog fremgangsmåde til anvendelse deraf | |
WO2007122580A3 (fr) | Compositions et méthodes utiles dans le traitement de maladies respiratoires | |
WO2006122250A3 (fr) | Antagonistes du recepteur (vr1) du sous-type 1 du recepteur de vanilloide et utilisations afferentes | |
NO20074256L (no) | Fremstilling av stopte legemer fra ligocellulosebaserte finpartiklete materialer | |
DK1776010T3 (da) | Fremgangsmåde til fremstilling af vandige aktivstofsammensætninger af aktivstoffer, som er tungt oplöselige i vand | |
ATE457655T1 (de) | Verfahren zur herstellung einer wässrigen suspension und einer pulverförmigen zubereitung eines oder mehrerer carotinoide | |
ATE517621T1 (de) | Verwendung von ampk-aktivierenden imidazol- derivaten, herstellungsverfahren dafür und diese enthaltende pharmazeutische zusammensetzungen | |
WO2007031512A3 (fr) | Derives de biphenylamidine pesticides | |
NO20053214L (no) | Fremgangsmate for fremstilling av pulveraktige sammensetninger av fettloselige forbindelser. | |
NZ587051A (en) | Isoquinolinone derivatives, compositions and methods of inhibiting phosphatidyl inositol-3 kinase (pi3 kinase) | |
WO2006092409A3 (fr) | Produits microencapsules a liberation rapide | |
WO2007125501A3 (fr) | Compositions et procédés utiles pour le traitement d'une maladie respiratoire | |
CL2007003061A1 (es) | Compuestos derivados de 3,5-dioxi-benzamida; proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una enfermedad mediada a traves de glk, tal como la diabetes tipo 2. | |
UA86914C2 (ru) | Пестицидная композиция, способ ее получения и применение для борьбы с вредителями, живущими в почве и на поверхности почвы | |
NO20074480L (no) | Hurtig massefuktingsmetode for fremstilling av kalsium-inneholdende sammensetninger | |
NO20062082L (no) | Pellets inneholdende venlafaksinhydroklorid | |
WO2010059534A3 (fr) | Excipient à base de cellulose microcristalline granulaire directement compressible, procédé de fabrication et utilisation de cet excipient | |
ATE471930T1 (de) | 3-aminocarbazolverbindungen, pharmazeutische zusammensetzungen, die diese enthalten, und verfahren zu deren herstellung | |
MX2009010363A (es) | Compuestos de 1,3-tiazol-2(3h)-ilideno como ligandos del receptor canabinoide. | |
ATE514415T1 (de) | Verfahren zur reduzierung der symptome von sodbrennen und gastroösophagealer reflux- krankheit (gerd) durch spezifische polysaccharide | |
WO2007024744A3 (fr) | Composes de carboxamide heterocycliques en tant qu'agents pharmaceutiques | |
PL1685225T3 (pl) | Środek wiążący dla matryc zestalających | |
HRP20180077T1 (hr) | Farmaceutski sastav koji sadrži statin | |
ATE517644T1 (de) | Mikrogelpartikel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |